Results 191 to 200 of about 436,801 (327)

The Evaluation of Oxidative Stress and High-Density Lipoprotein Cholesterol Levels in Diffuse Large B-Cell Lymphoma [PDF]

, 2019
Mihnea‐Alexandru Găman, Mirela Elena Epîngeac, Amelia Maria Găman   +2 more
openalex   +1 more source

There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5 [PDF]

, 2020
Hsuan Chiu, Pei-Yu Wu, Jiun‐Chi Huang, Hung‐Pin Tu, Ming‐Yen Lin, Szu‐Chia Chen, Jer‐Ming Chang   +6 more
openalex   +1 more source

The outcomes of electronic personal health records in patients with heart failure or coronary artery disease

ESC Heart Failure, Volume 12, Issue 2, Page 1464-1468, April 2025.
Abstract Background There are limited data on the efficacy of smartphone‐based personal health records (PHRs) in patients with cardiovascular disease. This study aimed to examine the processes, outcomes and challenges associated with the implementation of integrated PHRs in patients with heart failure (HF) or coronary artery disease (CAD). Methods This
Kotaro Nochioka, Satoshi Yasuda, Takashi Shiroto, Saori Yamamoto, Haruka Sato, Yuhi Hasebe, Shigeo Godo, Makoto Nakano, Tomohiko Shindo, Kensuke Nishimiya, Kiyotaka Hao, Jun Takahashi, Keisuke Ido, Yoichi Kakuta, Hiroaki Shimizu, Hiroaki Shimokawa, Masaharu Nakayama   +16 more
wiley   +1 more source

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and age-related macular degeneration: insights from two observational studies. [PDF]

Front Med (Lausanne)
Chen X, Li H, Jiao Z, Liu Y, Wu Y, Qiu X, Zou Y, Liu G.   +7 more
europepmc   +1 more source

High Density Lipoprotein Cholesterol Measurement [PDF]

, 2020
openaire   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and abdominal aortic calcification in adults: a cross-sectional study. [PDF]

Front Cardiovasc Med
Zhang J, Ning Y, Bai R, Song L, Wang H.
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Is high-density lipoprotein cholesterol a prognostic marker in epithelial ovarian cancer? [PDF]

Rev Assoc Med Bras (1992)
Uçar M, Yılmaz M, Erdiş E, Yücel B, Şakalar T.   +4 more
europepmc   +1 more source

Enhanced Cholesterol Efflux by Tyrosyl Radical-oxidized High Density Lipoprotein Is Mediated by Apolipoprotein AI-AII Heterodimers [PDF]

, 1998
Wenqi Wang, Deborah L. Merriam, Audric S. Moses, Gordon A. Francis   +3 more
openalex   +1 more source